The Prediabetes Debate: Is It a Useful Diagnosis or Potentially Harmful?

A prediabetes diagnosis can help some people make positive diet and lifestyle changes, but critics say it can also cause unnecessary worry and expense.
The Prediabetes Debate: Is It a Useful Diagnosis or Potentially Harmful?
Canva (5); Everyday Health
Prediabetes means your blood sugar level is higher than normal, but it’s not high enough to be considered type 2 diabetes.

If you’ve received this diagnosis, you may already feel as if you have diabetes. Your doctor has likely advised you to make diet and lifestyle changes, or perhaps they’ve prescribed medication to help lower your risk of developing type 2 diabetes.

However, some experts question how valuable the current definition of prediabetes is, and if having this diagnosis is in a patient’s best interests.

Here’s what you need to know about the current debate, and how to approach a prediabetes diagnosis from your doctor.

What Is a Prediabetes Diagnosis?

Prediabetes is not a disease itself, but rather a set of conditions that suggest a person is at a higher risk than normal to develop diabetes, which is a disease characterized by hyperglycemia, or high blood glucose (sugar).

The American Diabetes Association (ADA) coined the term “prediabetes” in the early 2000s to encourage healthcare providers to intervene earlier when patients develop high blood sugar.

The ADA uses the hemoglobin A1C blood test, which shows a person’s average blood sugar levels over the past three months, to diagnose prediabetes.

“It measures the amount of sugar attached to hemoglobin, a protein found in your red blood cells,” explains Shiara Ortiz-Pujols, MD, obesity medicine specialist at Northwell Staten Island University Hospital in New York. “Because it is an average over three months, it is not affected by things that you may have eaten over the past week or 24 hours and therefore it can give you a better sense of how much glucose you have in your blood system,” she says. “In addition, this test does not require you to fast beforehand.”

According to current ADA guidelines, results indicating prediabetes are:

  • An A1C of 5.7 to 6.4 percent, or average blood glucose for the past two to three months
  • Fasting plasma glucose (FPG) levels of 100 to 125 milligrams per deciliter (mg/dL), or blood glucose levels after fasting for at least eight hours
  • Oral glucose tolerance test (OGTT) levels of 140 to 199 mg/dL, or your blood glucose levels before and two hours after you drink a special sweet drink

The History of the Term ‘Prediabetes’

In 2009, an International Expert Committee with members appointed by the ADA, the European Association for the Study of Diabetes (EASD), and the International Diabetes Federation (IDF) issued a report meant to recommend the use of the A1C test for the diagnosis of diabetes.

The committee also recommended that diabetes should be diagnosed when patients have an A1C of 6.5 percent, and that people with readings between 6.0 and 6.5 percent “should receive demonstrably effective preventive interventions.”

However, the committee did not embrace the term prediabetes, which they described as “problematic because it suggests that all individuals so classified will develop diabetes and that individuals who do not meet these glycemia-driven criteria (regardless of other risk factor values) are unlikely to develop diabetes — neither of which is the case.”

Nevertheless, the ADA decided to stick with the term “prediabetes” and lowered the A1C threshold for diagnosing prediabetes from 6.1 to 5.7 percent, a move that the rest of the committee did not endorse.

The Centers for Disease Control and Prevention (CDC) followed suit with the same criteria and use of the term, “prediabetes.”

 “The American Diabetes Association (ADA) continues to set the standards of care for diabetes in the United States. CDC updates care guidelines, including diagnostic recommendations, in accordance with ADA,” says Christopher Holliday, PhD, director of the CDC’s Division of Diabetes Translation.
The World Health Organization (WHO), meanwhile, does not use the term “prediabetes,” but instead identifies two states that indicate a high risk for developing diabetes: impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG).

 WHO describes these conditions as “intermediate conditions in the transition between normality and diabetes,” adding that “people with IGT or IFG are at high risk of progressing to type 2 diabetes, although this is not inevitable.”
Currently, research suggests that about 84 million adults in the United States have prediabetes; it affects more than 1 in 3 American adults under age 65 and half of people over 65.

Risk Factors for Prediabetes

According to the CDC, prediabetes risk factors include:

  • Being a person who is overweight or who has obesity
  • Being 45 years or older
  • Having a family history of diabetes
  • Having had gestational diabetes
  • Being physically active fewer than three times a week
  • Giving birth to a baby weighing more than 9 pounds
  • Being of African American, Hispanic/Latino, American Indian, Alaska Native, Pacific Islander, or some Asian American ethnicities and races

Benefits of an Early Prediabetes Diagnosis

One benefit of diagnosing people with prediabetes based on ADA criteria is the condition is easier to treat in its early stages, Dr. Ortiz-Pujols says.

“This is what you would see with any chronic disease. The earlier that it is caught, the more likely you will have successful treatment — the later a disease is identified the more likely that it will progress to more significant disease,” she explains.

The medical complications that can arise from diabetes are numerous and can be life-threatening. They include heart disease; kidney disorders; periods of hypoglycemia (low blood sugar); diabetic neuropathy (nerve damage), which can be painful or lead to foot and limb injuries, as well as ulcers, deformities or even amputations; blindness; digestive disorders; skin problems; sexual dysfunction; teeth and gum problems; and difficulty regulating blood pressure.

Benefits of Lifestyle Changes

Intervening early opens a discussion about lifestyle changes, including nutrition, physical activity, and sleep, that can decrease a person’s risk of developing type 2 diabetes and other health problems, says Lisal Folsom, MD, medical director in the adult endocrinology division at the Wendy Novak Diabetes Institute at Norton Healthcare in Louisville, Kentucky.

“A diagnosis of prediabetes is a beautiful opportunity for somebody to assess their health and figure out ways that they can change what they're doing to ideally reverse prediabetes or to prevent the progression from prediabetes to diabetes,” she says. “But if you have the diagnosis, that's an impetus to make some changes, whereas if you didn't know, you wouldn't know that you needed to do anything differently.”

Studies have shown that lifestyle interventions with individualized reduced calorie eating plans are highly effective at preventing or delaying type 2 diabetes and improving other factors, such as blood pressure and inflammation, according to the ADA’s current “Standards of Care in Diabetes.”

Benefits of Weight Loss and Metformin

A landmark randomized controlled trial known as the Diabetes Prevention Program (DPP) looked at methods to delay or prevent diabetes in approximately 3,000 people with prediabetes. It found that after approximately three years, an intensive lifestyle intervention focused on weight loss reduced participants’ risk of developing diabetes by 58 percent. Intervention with the diabetes drug metformin, which is commonly prescribed off-label for prediabetes, reduced the incidence of diabetes by 31 percent, compared with placebo.

Ten years later, diabetes incidence was reduced by 34 percent in the lifestyle group and 18 percent in the metformin group compared with placebo, according to the Diabetes Prevention Program Outcomes Study (DPPOS).

More than two decades later, diabetes incidence was reduced by 25 percent in the lifestyle intervention group and by 18 percent in the metformin group, compared with the placebo group, per the DPPOS.

 

Potential Harms of Diagnosing Prediabetes

Experts say there are several drawbacks to diagnosing prediabetes, including overdiagnosis, overtreatment, causing unnecessary anxiety and stress in patients, and the financial burden of tests and treatments.

Overdiagnosis of Prediabetes and Overtreatment

Critics of the current definition of prediabetes under ADA guidelines argue that many people with this diagnosis will never develop the disease.


A review published in 2018 of 103 studies found that while the development of new type 2 diabetes in people with prediabetes generally increased over time, many participants also reverted from prediabetes back to normal blood glucose levels.


Overtreatment is also an issue. While addressing prediabetes is crucial for preventing type 2 diabetes and related health issues, intervening too much can lead to unnecessary stress and complications, says Maria Teresa Anton, MD, endocrinologist and educator at Pritikin Longevity Center in Miami.

“Overzealous intervention, such as excessive medication or overly restrictive diets, may not only diminish a patient's quality of life but also foster anxiety around food and health,” she says. “It’s important to focus on balanced, evidence-based lifestyle modifications that promote long-term well-being rather than solely aiming for clinical numbers. A thoughtful, individualized approach ensures that patients are supported in making sustainable changes without the risks associated with overtreatment.”

Weighing the Pros and Cons of Medication

Overmedicating can also be an issue. The ADA recommends metformin for people with prediabetes, particularly if the person has obesity, is over age 60, or has a history of gestational diabetes.

In addition to helping to prevent diabetes in some people, metformin has also been shown to have significant anti-aging effects and to weaken the progression of various aging-related diseases, though more research is needed.

A review and meta-analysis published in 2024 found that another class of drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), combined with lifestyle modification proved to be a more effective therapy for managing prediabetic patients than lifestyle modification alone.

However, while certain medications can reduce diabetes risk, they may not be necessary for everyone diagnosed with prediabetes, especially for those at a low risk of progression, says La’Tonzia Adams, MD, a clinical pathologist and representative for the College of American Pathologists (CAP) in Portland, Oregon.

“Unnecessary medication introduces the potential for side effects, which can lower patients’ quality of life and adherence to treatment plans,” she says, noting that glucose levels are only one of several factors that can indicate a person’s risk of disease progression.

One article argues that metformin — a drug most people will have to take for years, if not the rest of their lives — shouldn’t be prescribed to people with prediabetes who have a relatively low risk of developing diabetes because the minimal benefits aren’t worth potential side effects.

Common side effects of metformin include diarrhea, bloating, and other gastrointestinal symptoms.

Long-term use of metformin may also lead to vitamin B12 deficiency, according to the ADA.

 
Then there’s the financial burden. Generic metformin, for example, retails for about $10 to $30 for 60 500 mg tablets.

 While this is relatively inexpensive compared with other type 2 diabetes drugs, healthcare providers may also suggest people with prediabetes get more frequent follow-up visits and lab tests, which can be expensive, says Melissa Chambers, DO, a pediatric endocrinologist at Phoenix Children’s in Arizona. 

Variations in Prediabetes Diagnosis

Another criticism of diagnosing prediabetes is that variations in diagnostic criteria and inconsistencies in A1C levels and fasting glucose measurements can create confusion among clinicians and patients, Dr. Anton says.

As mentioned above, criteria for diagnosing prediabetes can differ from organization to organization, such as from the ADA to the WHO.

The test results can also be problematic. Discrepancies in A1C and fasting glucose results may arise due to variations in red blood cell turnover (as seen in people with anemia or other blood conditions), changes in red blood cell production, or certain genetic variants, Anton explains.

Additionally, she says, A1C test results may not fully reflect glucose level fluctuations that happen after eating or during periods of hypoglycemia (low blood sugar).

Another downside of the A1C test is that levels can vary among people of different ethnicities and races, Ortiz-Pujols notes. In particular, non-Hispanic Black people tend to have higher A1C levels than white people.

Factors such as stress, medications, and hormonal fluctuations can also cause high blood sugar.

“These discrepancies may lead to misdiagnosis, inappropriate treatment strategies, and a lack of standardized care,” says Anton, pointing to the need for "more unified guidelines and better education for both healthcare providers and patients.”

Ethical Considerations

While “medicalization” of a non-disease like prediabetes can be controversial, a prediabetes diagnosis can help equip patients with the tools they need to stave off not only type 2 diabetes but also associated long-term health risks like kidney disease and heart disease.

“Without the medicalization of [prediabetes], the onus of action is left on the person affected by the condition, which we know does not necessarily activate nor empower the person to do something to reverse the course of the condition,” Ortiz-Pujols says. Medicalization can facilitate more research on the issue as well as effective prevention strategies, she adds.

Deciding whether to diagnose a patient with prediabetes requires careful ethical consideration, Dr. Adams says. If the diagnosis leads to unnecessary anxiety, expense, and interventions without clear evidence of benefit, it could arguably harm patients more than it helps them, and raise questions about whether the diagnosis primarily serves the patient or other interests.

“The question of whether the ‘pre-disease’ state should be treated, and how aggressively, raises important ethical issues,” she explains. “Addressing these issues involves balancing prevention with the risks of overtreatment, ensuring that healthcare practices are not primarily driven by pharmaceutical or medical industry incentives but are genuinely aimed at promoting long-term health and well-being.“

The Business of Prediabetes

To be sure, the prediabetes market is a gold mine. Its global value was 201.62 million in 2023 and is projected to grow at a compound annual growth rate of 7.21 percent from 2024 to 2030, according to one report. Medications like metformin are largely propelling that growth.

Additionally, there are more than 15 prediabetes drugs currently in the pipeline.

Adams draws a parallel to other conditions that may be overdiagnosed and overmedicated. For example, recommending medication for people with borderline high blood pressure can be controversial, since lifestyle changes may be equally effective.

“Treating mild hypertension pharmacologically can create a dependency on medication while sometimes failing to address underlying health behaviors, raising similar questions about whether this approach best serves patients’ health,” she says.

However, intervention can be critical for those who are truly at risk of developing diabetes.

“This debate boils down to finding a balanced approach — one that doesn't underplay the risks for those truly on the path to diabetes while avoiding unnecessary treatment for those unlikely to progress,” Adams says.

What Should I Do if I’m Diagnosed With Prediabetes?

If you have test results that come back in the range for prediabetes, remember that it’s an indication of risk, and most of what happens next is under your control. “Knowledge is power,” Dr. Folsom says.

Keep calm, and do the following:

  • Ask your primary care doctor about what you can do to lower your risk of progressing to diabetes, including eating a healthier diet, exercising more, losing weight, and possibly taking medication.
  • Seek a referral to a registered dietitian-nutritionist in case you may benefit from changing your eating habits.

“If somebody has prediabetes, the first thing I'm going to recommend is look at your nutrition, include more fruits and vegetables, switch over to whole grains, make sure you're eating good, clean whole foods and lean proteins, adding in plant foods like beans and nuts and seeds and limiting processed foods, sugary beverages, and desserts, and then increasing physical activity,” Folsom says.

The CDC-led National Diabetes Prevention Program recommends that most adults get 150 minutes of moderate activity every week.

People with prediabetes don’t usually need to monitor their glucose at home. However, your healthcare provider will likely recommend getting your A1C checked every one to two years, according to the CDC.

Above all, keep your diagnosis in perspective. Having prediabetes doesn’t mean you’re definitely going to develop diabetes. It’s simply a warning sign to make changes.

The Takeaway

  • The current protocol for diagnosing prediabetes isn’t perfect, and standards can differ from one organization to another, but most experts agree the diagnosis can help encourage healthy lifestyle changes and prevent disease when administered responsibly.
  • A prediabetes diagnosis can be anxiety-provoking, but some people diagnosed with prediabetes never develop diabetes, and lifestyle changes can help you avoid it.
  • If you’ve been diagnosed with prediabetes, talk to your doctor for personalized guidance.

Resources We Trust

Anna-L-Goldman-bio

Anna L. Goldman, MD

Medical Reviewer

Anna L. Goldman, MD, is a board-certified endocrinologist. She teaches first year medical students at Harvard Medical School and practices general endocrinology in Boston.

Dr. Goldman attended college at Wesleyan University and then completed her residency at Icahn School of Medicine at Mount Sinai Hospital in New York City, where she was also a chief resident. She moved to Boston to do her fellowship in endocrinology at Brigham and Women's Hospital. She joined the faculty after graduation and served as the associate program director for the fellowship program for a number of years.

Kate-Daniel-bio

Kate Daniel

Author
Kate Daniel is a journalist specializing in health and wellness. Previously, she was a reporter for Whidbey News Group in Washington, where she earned four regional awards for her work. Daniel has written for various outlets, including HealthDay, Nice News, and Giddy.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Prediabetes. Mayo Clinic. November 11, 2023.
  2. Lazris A et al. Prediabetes Diagnosis: Helpful or Harmful? American Academy of Family Physicians. December 2021.
  3. Understanding Diabetes Diagnosis. American Diabetes Association.
  4. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. July 2009.
  5. Piller C. Dubious Diagnosis. Science. March 8, 2019.
  6. Testing for Diabetes. Centers for Disease Control and Prevention. July May 15, 2024.
  7. Diabetes Mellitus. World Health Organization. November 14, 2024.
  8. Prediabetes. Cleveland Clinic. August 11, 2023.
  9. The Surprising Truth About Prediabetes. Centers for Disease Control and Prevention. May 15, 2024.
  10. Diabetes Complications. American Diabetes Association.
  11. Orchard TJ et al. Standards of Care in Diabetes–2024. Diabetes Care. January 1, 2024.
  12. Diabetes Prevention Program Research Group et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). November 14, 2009.
  13. Diabetes Prevention Program Research Group et al. New Data from Diabetes Prevention Program Outcomes Study Shows Persistent Reduction of Type 2 Diabetes Development Over 22-Year Average Follow-Up. American Diabetes Association. June 16, 2020.
  14. van Herpt TTW et al. Lifetime Risk to Progress From Pre-Diabetes to Type 2 Diabetes Among Women and Men: Comparison Between American Diabetes Association and World Health Organization Diagnostic Criteria. BMJ Open Diabetes Research and Care. November 19, 2020.
  15. Richter B et al. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Library. October 29, 2018.
  16. Chen S et al. Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms. Theranostics. March 6, 2022.
  17. Salamah HM et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome. June 14, 2024.
  18. Davidson MB. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. August 11, 2020.
  19. Metformin. MedlinePlus. February 4, 2024.
  20. Morris M. How Much Is Metformin Without Insurance? GoodRx. April 16, 2024.
  21. My blood sugar level is up even though I keep a consistent diet and exercise schedule. What could be the cause? Mayo Clinic. March 13, 2024.
  22. Prediabetes Market Size, Share & Trends Analysis Report By Drug Class (Diguanide, Thiazolidinediones), By Age Group (Children, Adult), By Region, And Segment Forecasts, 2024 - 2030. Grand View Research.
  23. Prediabetes – Pipeline Insight. Delve Insight. January 2024.
  24. Prediabetes. American Diabetes Association.
  25. What Is the National DPP? Centers for Disease Control and Prevention. May 15, 2024.
  26. Testing for Diabetes and Prediabetes: A1c. Centers for Disease Control and Prevention. May 15, 2024.